Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
The Lancet. Oncology|February 3, 2022
Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunitiesDiana D Shi, Jimmy A Guo, Hannah I Hoffman, et al.Biorxiv : the Preprint Server for Biology|April 27, 2026
KDM6 Enzymes are the Mechanistic Targets of Mutant IDH that Dictate Replication Stress SensitivityAlexander C-Y Tsai, Mathew D Lin, Vinesh T Puliyappadamba, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2025
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical TrialAyal A Aizer, Shyam K Tanguturi, Diana D Shi, et al.JAMA|February 19, 2026
Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical TrialAyal A Aizer, Kee-Young Shin, Paul J Catalano, et al.Neuro-Oncology|November 13, 2018
Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment toolPaul W Sperduto, Brian J Deegan, Jing Li, et al.International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain MetastasesPaul W Sperduto, Brian J Deegan, Jing Li, et al.Neuro-Oncology|October 25, 2025
Stable isotope tracing in human plasma-like medium reveals metabolic and immune modulation of the glioblastoma microenvironmentMilan R Savani, Mohamad El Shami, Kenji Miki, et al.Neuro-Oncology|March 28, 2026
Expanding the molecular grading criteria in IDH-mutant astrocytomaMichael Christian Virata, Jorge Samanamud, Cheyanne C Slocum, et al.Cell|September 18, 2018
Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in GliomaSamuel K McBrayer, Jared R Mayers, Gabriel J DiNatale, et al.Biorxiv : the Preprint Server for Biology|August 20, 2025
Mutant IDH silences GSX2 to reprogram neural progenitor cell fate and promote gliomagenesisYi Xiao, Diana D Shi, Lei Guo, et al.Pageof 4